Literature DB >> 52570

Establishment and some biological characteristics of human hepatoma cell lines.

I Dor, M Namba, J Sato.   

Abstract

Two cell lines of human hepatoma, HLE and HLF lines, were established in vitro from the hepatocellular carcinoma of a 68-year-old patient. One clone (HLEC) was obtained from a single HLE cell. The cells of HLE and HLEC were epithelial-like and both of these cells demonstrated glycogen granules in the cytoplasm when stained with periodic acid and Schiff reagent. Although HLF cells resembled fibroblasts in morphology, they appear to have originated from hepatoma cells, judging from epithelial characteristics in aggregates reconstituted by rotation culture and heterotransplantability. HLE cells produced alpha-fetoprotein until day 187 of culture, but HLF cells did not produce alpa-fetoprotein at any period examined. Chromosome number of both cell lines was distributed near the triploid range. HLF cells were transplantable into the cheek pouch of adult hamsters treated with cortisone acetate, but not HLE cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52570

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  36 in total

1.  Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model.

Authors:  M Takagi; N Fukuda; T Yoshida
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

2.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Sorafenib suppresses the cell cycle and induces the apoptosis of hepatocellular carcinoma cell lines in serum-free media.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi; Takanobu Yoshida
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

4.  Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.

Authors:  Jiang Xiao; Hong-Song Chen; Ran Fei; Xu Cong; Li-ping Wang; Yan Wang; Dong Jiang; Lai Wei; Yu Wang
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

5.  Noninvasive discrimination between human normal and cancer cells by analysis of intracellular distribution of phase-shift data.

Authors:  Mutsumi Takagi; Naochika Tokunaga
Journal:  Cytotechnology       Date:  2015-04-09       Impact factor: 2.058

6.  Vitronectin secretion by hepatic and non-hepatic human cancer cells.

Authors:  H Yasumitsu; N Seo; E Misugi; H Morita; K Miyazaki; M Umeda
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

7.  Establishment and characterization of a new human hepatocellular carcinoma cell line.

Authors:  L He; K J Isselbacher; J R Wands; H M Goodman; C Shih; A Quaroni
Journal:  In Vitro       Date:  1984-06

8.  Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells.

Authors:  Takumi Kawaguchi; Sho-Ichi Yamagishi; Minoru Itou; Koji Okuda; Shuji Sumie; Ryoko Kuromatsu; Masahiro Sakata; Mitsuhiko Abe; Eitaro Taniguchi; Hironori Koga; Masaru Harada; Takato Ueno; Michio Sata
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

9.  Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo.

Authors:  W Jiao; K Miyazaki; Y Kitajima
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Twist expression promotes migration and invasion in hepatocellular carcinoma.

Authors:  Noriyuki Matsuo; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Naoki Ueda; Shigetomi Tanaka; Shinichi Nishina; Yutaka Nakanishi; Masayuki Uemura; Akinobu Takaki; Shinichiro Nakamura; Yoshiyuki Kobayashi; Kazuhiro Nouso; Takahito Yagi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.